36C25523Q0553_2 final.docx
DOCX document 234 KB Posted
- Solicitation number
- 36C25523Q0553
About this file
This document is a solicitation for sterile hazardous drug compounding services for the Kansas City Veterans Affairs Medical Center pharmacy. The solicitation seeks to establish multiple blanket purchase agreements to provide all chemotherapy agents, supplies, and compounding of hazardous drugs from September 2023 through December 2023. Pricing will be firm fixed price for each order placed against the BPAs, which are not binding contracts but provide an avenue for future orders that are not guaranteed. The solicitation lists over 100 chemotherapy agents and supplies that may be ordered and includes requirements for compounding, delivery, labeling, certification, and pricing of individual medications utilized for each patient. Responses are due by September 11, 2023, with orders to be delivered the following day. The Department of Veterans Affairs Veterans Health Administration VISN 15 is the contracting agency, with the Kansas City VA Medical Center as the primary location for delivered products and services.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Chemotherapy Infusion SOW.docx | DOCX document | |
| VHA PBM.pdf | ||
| Service Contract Act WD No 2015-5105 Rev 20.pdf | ||
| KCVA Common Supplies and Chemotherapy Agents List.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
PAGE 1 OF
1. REQUISITION NO.
2. CONTRACT NO.
3. AWARD/EFFECTIVE DATE
4. ORDER NO.
5. SOLICITATION NUMBER
6. SOLICITATION ISSUE DATE
a. NAME
b. TELEPHONE NO. (No Collect Calls)
8. OFFER DUE DATE/LOCAL
TIME
9. ISSUED BY
CODE
10. THIS ACQUISITION IS
UNRESTRICTED OR
SET ASIDE:
% FOR:
SMALL BUSINESS
HUBZONE SMALL
BUSINESS
SERVICE-DISABLED
VETERAN-OWNED
SMALL BUSINESS
WOMEN-OWNED SMALL BUSINESS
(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED
SMALL BUSINESS PROGRAM
EDWOSB
8(A)
NAICS:
SIZE STANDARD:
11. DELIVERY FOR FOB DESTINA-
TION UNLESS BLOCK IS
MARKED
SEE SCHEDULE
12. DISCOUNT TERMS
13a. THIS CONTRACT IS A
RATED ORDER UNDER
DPAS (15 CFR 700)
13b. RATING
14. METHOD OF SOLICITATION
RFQ
IFB
RFP
15. DELIVER TO
CODE
16. ADMINISTERED BY
CODE
17a. CONTRACTOR/OFFEROR
CODE
FACILITY CODE
18a. PAYMENT WILL BE MADE BY
CODE
TELEPHONE NO.
UEI:
EFT:
PHONE:
FAX:
17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED
SEE ADDENDUM
19.
20.
21.
22.
23.
24.
ITEM NO.
SCHEDULE OF SUPPLIES/SERVICES
QUANTITY
UNIT
UNIT PRICE
AMOUNT
(Use Reverse and/or Attach Additional Sheets as Necessary)
25. ACCOUNTING AND APPROPRIATION DATA
26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED.
27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA
ARE
ARE NOT ATTACHED
28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________
29. AWARD OF CONTRACT: REF. ___________________________________ OFFER
COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND
DATED ________________________________. YOUR OFFER ON SOLICITATION
DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY
(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE
ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED
SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:
30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED
AUTHORIZED FOR LOCAL REPRODUCTION
(REV. NOV 2021)
PREVIOUS EDITION IS NOT USABLE
Prescribed by GSA - FAR (48 CFR) 53.212
7. FOR SOLICITATION
INFORMATION CALL:
STANDARD FORM 1449
SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES
OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30
TBD
36C25523Q0553 08-21-2023 Chattman, Courtney 913-946-1975 09-11-2023 10:00
CDT
36C255 Department of Veterans Affairs Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway
Leavenworth KS 66048
X
424210 250 Employees
N/A
Department of Veterans Affairs Kansas City VA Medical Center 4801 Linwood Blvd Kansas City MO 64128 36C255 Department of Veterans Affairs Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway
Leavenworth KS 66048
36C255
Financial Services Center http://www.fsc.va.gov/einvoice.asp
Austin TX 877-353-9791 512-460-5429
See CONTINUATION Page Pharmacy Compounding Services - Kansas City VAMC
The purpose of this solicitation is to establish a MULTIPLE-AWARD Blanket Purchase Agreement (BPA) for the Kansas City VA Medical Center. The Period of Performance is September 18, 2023 - December 31, 2023.
Pricing will be Firm Fixed Price (FFP) for each order.
IAW FAR 13.004, this BPA is not a binding contract. A contract only arises when the Government places an order that is properly accepted by the BPA holder. Placement of orders are not guaranteed.
See Section B.1 Performance Work Statement for full details.
Service Contract Act WD # 2015-5105, Rev 20 does apply.
CO POC: Courtney Chattman; Courtney Chattman@va.gov
No questions will be accepted after September 4, 2023.
See CONTINUATION Page
TBD
Courtney Chattman
Table of Contents
| SECTION A | 1 |
| A.1 SF 1449 SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES | 1 |
| SECTION B - CONTINUATION OF SF 1449 BLOCKS | 4 |
| B.1 PERFORMANCE WORK STATEMENT | 4 |
| B.2 PRICE/COST SCHEDULE | 8 |
| ITEM INFORMATION | 8 |
| B.3 DELIVERY SCHEDULE | 18 |
| B.4 TERMS AND CONDITIONS | 18 |
| B.5 ADMINISTRATIVE DATA | 19 |
| B.6 PRICING DATA | 19 |
| B.7 OPTION TO EXTEND THE TERM OF THE BPA | 20 |
| B.8 SEGREGATION OF COSTS | 20 |
| B.9 GENERAL SERVICES ORDERS | 20 |
| B.10 AUTHORIZED LIMITS | 21 |
| B.11 OBLIGATION OF FUNDS | 21 |
| B.12 INVOICES | 21 |
| B.13 PERIOD OF PERFORMANCE | 21 |
| B.14 AUTHORIZED INDIVIDUALS | 21 |
| B.15 ORDER FORMAT | 22 |
| B.16 AUTHORIZED REPRESENTATIVES | 22 |
| B.17 FEDERAL HOLIDAYS | 23 |
| B.18 ORDERING MANAGEMENT | 23 |
| B.19 PERFORMANCE | 24 |
| B.20 MANAGEMENT CONTROL | 25 |
| B.21 PRECEDENCE | 25 |
| SECTION C - CONTRACT CLAUSES | 26 |
| ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES | 26 |
| C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998) | 26 |
| C.2 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022) | 26 |
| C.3 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018) | 27 |
| C.4 VAAR 852.204-71 INFORMATION AND INFORMATION SYSTEMS SECURITY (FEB 2023) | 27 |
| C.5 VAAR 852.208-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTORS – ORDERS or BPAs (JAN 2023) (DEVIATION) | 36 |
| C.6 VAAR 852.208-71 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTOR COMMITMENTS-ORDERS AND BPAS (JAN 2023) (DEVIATION) | 37 |
| C.7 VAAR 852.211-72 TECHNICAL INDUSTRY STANDARDS (NOV 2018) | 38 |
| C.8 VAAR 852.211-76 LIQUIDATED DAMAGES – REIMBURSEMENT FOR DATA BREACH COSTS (FEB 2023) ALTERNATE I (FEB 2023) | 38 |
| C.9 VAAR 852.215-70 SERVICE-DISABLED VETERAN-OWNED AND VETERAN-OWNED SMALL BUSINESS EVALUATION FACTORS (JAN 2023) (DEVIATION) | 39 |
| C.10 VAAR 852.215-71 EVALUATION FACTOR COMMITMENTS (OCT 2019) | 40 |
| C.11 VAAR 852.232-72 ELECTRONIC SUBMISSION OF PAYMENT REQUESTS (NOV 2018) | 40 |
| C.12 VAAR 852.242-71 ADMINISTRATIVE CONTRACTING OFFICER (OCT 2020) | 42 |
| C.14 VAAR 852.247-72 MARKING DELIVERABLES (OCT 2018) | 42 |
| C.15 52.212-5 CONTRACT TERMS AND CONDITIONS REQUIRED TO IMPLEMENT STATUTES OR EXECUTIVE ORDERS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (JUN 2023) | 42 |
| SECTION D - CONTRACT DOCUMENTS, EXHIBITS, OR ATTACHMENTS | 51 |
| SECTION E - SOLICITATION PROVISIONS | 52 |
| ADDENDUM to FAR 52.212-1 INSTRUCTIONS TO OFFERORS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES | 52 |
| E.1 52.252-1 SOLICITATION PROVISIONS INCORPORATED BY REFERENCE (FEB 1998) | 52 |
| E.2 52.204-24 REPRESENTATION REGARDING CERTAIN TELECOMMUNICATIONS AND VIDEO SURVEILLANCE SERVICES OR EQUIPMENT (NOV 2021) | 52 |
| E.3 52.209-7 INFORMATION REGARDING RESPONSIBILITY MATTERS (OCT 2018) | 55 |
| E.4 52.233-2 SERVICE OF PROTEST (SEP 2006) | 56 |
| E.5 VAAR 852.215-72 NOTICE OF INTENT TO RE-SOLICIT (OCT 2019) | 57 |
| E.6 VAAR 852.233-70 PROTEST CONTENT/ALTERNATIVE DISPUTE RESOLUTION (OCT 2018) | 57 |
| E.7 VAAR 852.233-71 ALTERNATE PROTEST PROCEDURE (OCT 2018) | 58 |
| E.8 VAAR 852.239-75 INFORMATION AND COMMUNICATION TECHNOLOGY ACCESSIBILITY NOTICE (FEB 2023) | 58 |
| E.9 VAAR 852.252-70 SOLICITATION PROVISIONS OR CLAUSES INCORPORATED BY REFERENCE (JAN 2008) | 59 |
| E.10 ADDENDUM to 52.212-2 EVALUATION—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES | 59 |
| E.11 52.212-3 OFFEROR REPRESENTATIONS AND CERTIFICATIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES (DEC 2022) | 60 |
| LIST OF ATTACHMENTS | 80 |
SECTION B - CONTINUATION OF SF 1449 BLOCKS
B.1 PERFORMANCE WORK STATEMENT
1. BACKGROUND:
The Department of Veterans Affairs has a requirement for compounding hazardous chemotherapy agents for the Kansas City VA Medical Center (KCVAMC) located at 4801 E Linwood Blvd, Kansas City, MO 64128. These compounding services are necessary to provide chemotherapy treatments to Veterans diagnosed with specific medical conditions. KCVAMC has approximately 10‐24 patients on any given day Monday‐Friday for Chemotherapy Infusion. Compounding must be done at an FDA 503A compliant facility and meet all state and federal laws. Contract is an emergent request for a period of performance as follows:
The Government anticipates awarding Firm-Fixed Price Multiple-Award Blanket Purchase Agreements (BPA) for this requirement. There is no minimum price required and this is for contingency purposes.
Estimated Period of Performance: September 18, 2023 – December 31, 2023
2. SCOPE OF WORK:
Services Non‐Personal; Contractor shall provide all chemotherapy agents, IV Tubing, closed system drug transfer devices, and any other items deemed necessary. All Hazardous Chemotherapy Agents will be aseptically compounded based on patient specific orders.
Prescription orders will be submitted via encrypted email or fax. Once submitted, VA staff will confirm receipt of order with the Contractor via phone or encrypted email.
· Orders from KCVAMC will be submitted by noon CST to receive next day by 9am CST.
· Each prescription will include the following:
· Patient name
· Patient address (with first order for each patient)
· Patient phone number (with first order for each patient)
· Gender
· Date of Birth
· Height
· Weight
· Allergies
· Drug dosage
· Diluent and volume
· Rate
· Administration/procedure date
· Prescribing physician/signature
Compounded orders shall be transported via Courier, overnight mail service, or any other means necessary to ensure receipt prior to infusion date/time to the following locations:
Orders for Kansas City, MO:
Kansas City VA Medical Center Inpatient Pharmacy Room V2-710 4801 Linwood Boulevard Kansas City, MO 64128
Items shall be delivered to the KCVAMC by 9:00am CST, the day after orders are submitted.
Compounding, labeling, and beyond use dating/expiration dating will be based on USP 797, USP 800 and Federal Law.
A list of the common chemotherapy agents and supplies will be provided directly to the Contractor.
All drugs are to be supplied by the Contractor. See attachment “KCVAMC Common Supplies and Chemotherapy Agents List”. This list is not inclusive, and agents may be added or deleted as the mission needs change.
Contractor shall invoice for billable units for the amount of medication utilized for each individual patient.
Contractor shall provide current and future certification reports for the sterile compounding areas and compounding hoods. In the case of any failures, contractor shall provide action plans for corrections of deficiencies and testing results showing the failures have been corrected.
Contractor shall update and provide the “VHA PBM Assessment Guide for Compounded Sterile Preparations within VAMCs and Outsourced Compounding Pharmacies” at time of solicitation response and annually.
Shipping fees shall be included with the order. All shipments for weekend delivery will be arranged as needed to ensure delivery can be successfully completed.
Specifications below for compatibility needs:
· Bag Spike Rule: All chemo and Mabs
· Primary IV Set: BD Secondary Set (REF 11426965) or interchangeable set
· Secondary IV Set: BD Secondary Set (REF 2204-0007) or interchangeable set
· In‐line Filter: All necessary compounded materials per manufacture recommendation
· Filter Rules: Filter is required for Abatacept, Avelumab, Cabazitaxel, Cetuximab, Daratumumab, Durvalumab, Pembrolizumab, Ramucirumab, Siltuximab, and others as recommended by manufacturing guidelines.
· Special Priming: Prime tubing with base fluid prior to adding medications.
· Total Volume Calculations – Overfills in IV Bags: Total volume only calculated when specified in order. No adjustments made for overfill.
· Close System Device: Equashield
· Pre‐meds: none
· Other: Occasionally need 5‐FU in WalkMed bags
Refer to attachment “KCVAMC Common Supplies and Chemotherapy Agents List” for more details for each individual chemotherapy agent. The Contractor will refer to this list to understand what tubing, filters, and other supplies are used for each compounded chemotherapy agent.
3. WORK HOURS:
KCVAMC Inpatient Pharmacy (Room V2-710) is open to receive medications 24/7.
4. CONTINGENCY PLANNING:
The Contractor shall have a contingency backup plan in the event that compounding facility is affected by any certification discrepancies, equipment malfunctions, natural disasters, or other matters affecting performance of the contract. Contingency locations must meet the same criteria as stated herein.
5. COMPLIANCE WITH APPLICABLE LAWS AND REGULATIONS:
The Contractor shall ensure that services provided to the Government under this contract comply with all USP 797, USP 800, and other applicable guidelines for sterile compounding chemotherapy agents. The Contractor shall also ensure that all services provided to the Government under this contract comply with all Government mandated procedures, standards, and requirements.
Information Systems Officer, Information Protection:
The contractor will not have access to VA Desktop computers, nor will they have access to online resources belonging to the government while conducting services. If removal of equipment from the VA is required, any memory storage devices, such as hard drives, solid state drives and non‐volatile memory units will remain in VA control and will not be removed from VA custody.
Privacy Officer:
The contractor will have access to protected Patient Health Information (PHI), but it will not have the capability of accessing patient information during the services provided to the VA and if removal of equipment from the VA is required, any memory storage devices, such as hard drives, solid state drives and non‐volatile memory units will remain in VA control and will not be removed from VA custody. All research data available for Contractor analyses is de‐identified.
Records Manager:
1. Records Manager:
a. Citations to pertinent laws, codes and regulations such as 44 U.S.C chapters 21, 29, 31 and 33;
Freedom of Information Act (5 U.S.C. 552); Privacy Act (5 U.S.C. 552a); 36 CFR Part 1222 and Part 1228.
b. Contractor shall treat all deliverables under the contract as the property of the U.S. Government for which the Government Agency shall have unlimited rights to use, dispose of, or disclose such data contained therein as it determines to be in the public interest.
c. Contractor shall not create or maintain any records that are not specifically tied to or authorized by the contract using Government IT equipment and/or Government records.
d. Contractor shall not retain, use, sell, or disseminate copies of any deliverable that contains information covered by the Privacy Act of 1974 or that which is generally protected by the Freedom of Information Act.
e. Contractor shall not create or maintain any records containing any Government Agency records that are not specifically tied to or authorized by the contract.
f. The Government Agency owns the rights to all data/records produced as part of this contract.
g. The Government Agency owns the rights to all electronic information (electronic data, electronic information systems, electronic databases, etc.) and all supporting documentation created as part of this contract. Contractor must deliver sufficient technical documentation with all data deliverables to permit the agency to use the data.
6. QUALITY ASSURANCE SURVEILLANCE PROGRAM:
The Government will monitor the Contractor’s performance under this contract with the below performance objectives:
| Task |
| ID |
| Indicator |
| Standard |
| Acceptable Quality Level |
| Method of Surveillance |
| Incentive |
| Rating |
| General |
| 1 |
| Orders processed accurately |
| Contractor shall ensure all orders are processed per prescription order |
| 100% |
| Labeling |
| Positive Past Performance &Exercise of Option Period |
| 2 |
| Orders received prior to infusion date/time |
| Contractor shall comply with all safety requirements |
| 100% |
| Validated receipt of order |
| Positive Past Performance &Exercise of Option Period |
| 3 |
| Contractor maintains certifications required for compounding |
| Contractor shall furnish copies of certificates and complete VHA PBM Assessment Annually |
| 100% |
| Validated receipt of certificates and/or assessment |
| Positive Past Performance &Exercise of Option Period |
(End of Performance Work Statement)
B.2 PRICE/COST SCHEDULE
ITEM INFORMATION
| ITEM NUMBER |
| DESCRIPTION OF SUPPLIES/SERVICES |
| QUANTITY |
| UNIT |
| UNIT PRICE |
| AMOUNT |
| 19.00 |
| EA |
| ______________ |
| ______________ |
Arsenic trioxide 12mg
LOCAL STOCK NUMBER: 63459-0601-06
| 18.00 |
| EA |
| ______________ |
| ______________ |
Atezolizumab 1200mg
LOCAL STOCK NUMBER: 50242-0917-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Azacitadine 100mg
LOCAL STOCK NUMBER: 00781-3253-94
| 24.00 |
| EA |
| ______________ |
| ______________ |
Bendamustine 100mg
LOCAL STOCK NUMBER: 63459-0348-04
| 20.00 |
| EA |
| ______________ |
| ______________ |
Bevacizumab-bvzr 100mg
LOCAL STOCK NUMBER: 00069-0315-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Bortezomib 3.5mg
LOCAL STOCK NUMBER: 63323-0821-10
| 18.00 |
| EA |
| ______________ |
| ______________ |
Brentuximab vedotin 50mg
LOCAL STOCK NUMBER: 51144-0050-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Cabazitaxel 60mg
LOCAL STOCK NUMBER: 00024-5824-11
| 19.00 |
| EA |
| ______________ |
| ______________ |
Carboplatin 150mg
LOCAL STOCK NUMBER: 00703-4248-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Carfilzomib 60mg
LOCAL STOCK NUMBER: 76075-0101-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Cetuximab 100mg
LOCAL STOCK NUMBER: 66733-0948-23
| 21.00 |
| EA |
| ______________ |
| ______________ |
Cisplatin 100mg
LOCAL STOCK NUMBER: 63323-0103-51
| 20.00 |
| EA |
| ______________ |
| ______________ |
Cladribine 10mg
LOCAL STOCK NUMBER: 63323-0140-10
| 20.00 |
| EA |
| ______________ |
| ______________ |
Cyclophosphamide 1g
LOCAL STOCK NUMBER: 10019-0956-01
| 21.00 |
| EA |
| ______________ |
| ______________ |
Cytarabine 100mg
LOCAL STOCK NUMBER: 61703-0319-22
| 20.00 |
| EA |
| ______________ |
| ______________ |
Cytarabine 2g
LOCAL STOCK NUMBER: 63323-0120-20
| 20.00 |
| EA |
| ______________ |
| ______________ |
Dacarbazine 200mg
LOCAL STOCK NUMBER: 63323-0128-20
| 24.00 |
| EA |
| ______________ |
| ______________ |
Daratumumab 400mg
LOCAL STOCK NUMBER: 57894-0502-05
| 20.00 |
| EA |
| ______________ |
| ______________ |
Decitabine 50mg
LOCAL STOCK NUMBER: 67457-0316-25
| 20.00 |
| EA |
| ______________ |
| ______________ |
Docetaxel 80mg
LOCAL STOCK NUMBER: 16729-0267-64
| 20.00 |
| EA |
| ______________ |
| ______________ |
Doxorubicin 50mg
LOCAL STOCK NUMBER: 00069-3032-20
| 18.00 |
| EA |
| ______________ |
| ______________ |
Durvalumab 500mg
LOCAL STOCK NUMBER: 00310-4611-50
| 18.00 |
| EA |
| ______________ |
| ______________ |
Eculizumab 300mg
LOCAL STOCK NUMBER: 25682-0001-01
| 24.00 |
| EA |
| ______________ |
| ______________ |
Elotuzumab 300mg
LOCAL STOCK NUMBER: 00003-2291-11
| 22.00 |
| EA |
| ______________ |
| ______________ |
Etoposide 100mg
LOCAL STOCK NUMBER: 63323-0104-05
| 24.00 |
| EA |
| ______________ |
| ______________ |
Fam-trastuzumab deruxtecan-nxki 100mg
LOCAL STOCK NUMBER: 65597-0406-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Ferric carboxymaltose 750mg
LOCAL STOCK NUMBER: 00517-0650-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Fludarabine 50mg
LOCAL STOCK NUMBER: 63323-0192-02
| 22.00 |
| EA |
| ______________ |
| ______________ |
Fluorouracil 1g
LOCAL STOCK NUMBER: 63323-0117-20
| 19.00 |
| EA |
| ______________ |
| ______________ |
Fluorouracil 500mg
LOCAL STOCK NUMBER: 63323-0117-10
| 20.00 |
| EA |
| ______________ |
| ______________ |
Fluorouracil 5g
LOCAL STOCK NUMBER: 63323-0117-61
| 20.00 |
| EA |
| ______________ |
| ______________ |
Fosaprepitant 150mg
LOCAL STOCK NUMBER: 00591-4385-79
| 20.00 |
| EA |
| _________________ |
| _______________ |
Fulvestrant 250mg
LOCAL STOCK NUMBER: 63323-0715-05
| 20.00 |
| EA |
| ______________ |
| _______________ |
Furosemide 100mg
LOCAL STOCK NUMBER: 63323-0280-10
| 19.00 |
| EA |
| ______________ |
| __________________ |
Furosemide 20mg
LOCAL STOCK NUMBER: 63323-0280-02
| 19.00 |
| EA |
| ______________ |
| ______________ |
Ganciclovir 500mg
LOCAL STOCK NUMBER: 63323-0315-10
| 20.00 |
| EA |
| ______________ |
| ______________ |
Gemcitabine 1g
LOCAL STOCK NUMBER: 00409-0181-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Gemcitabine 2g
LOCAL STOCK NUMBER: 00409-0182-01
| 19.00 |
| EA |
| ______________ |
| ______________ |
Gemcitabine 200mg
LOCAL STOCK NUMBER: 00409-0183-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Gentamicin Sulfate 80mg
LOCAL STOCK NUMBER: 63323-0010-02
| 18.00 |
| EA |
| ______________ |
| ______________ |
Idarubicin 10mg
LOCAL STOCK NUMBER: 00013-2586-91
| 20.00 |
| EA |
| ______________ |
| ______________ |
Idarubicin 20mg
LOCAL STOCK NUMBER: 00013-2596-91
| 21.00 |
| EA |
| ______________ |
| ______________ |
Idarubicin 5mg
LOCAL STOCK NUMBER: 00013-2576-91
| 19.00 |
| EA |
| ______________ |
| ______________ |
Ifosfamide 1g
LOCAL STOCK NUMBER: 10019-0925-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Ifosfamide 3g
LOCAL STOCK NUMBER: 10019-0926-02
| 18.00 |
| EA |
| ______________ |
| ______________ |
Infliximab 100mg
LOCAL STOCK NUMBER: 57894-0030-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Infliximab-abda 100mg
LOCAL STOCK NUMBER: 78206-0162-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Irinotecan 100mg
LOCAL STOCK NUMBER: 00009-7529-03
| 20.00 |
| EA |
| ______________ |
| ______________ |
Liposomal Doxorubicin 20mg
LOCAL STOCK NUMBER: 00338-0063-01
| 24.00 |
| EA |
| ______________ |
| ______________ |
Liposomal Doxorubicin 50mg
LOCAL STOCK NUMBER: 43598-0541-25
| 18.00 |
| EA |
| ______________ |
| ______________ |
Lurbinectedin 4mg
LOCAL STOCK NUMBER: 68727-0712-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Mepolizumab 100mg
LOCAL STOCK NUMBER: 00173-0881-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Mesna 1g
LOCAL STOCK NUMBER: 10019-0953-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Methotrexate 1g
LOCAL STOCK NUMBER: 61703-0408-41
| 19.00 |
| EA |
| ______________ |
| ______________ |
Mitomycin 5mg
LOCAL STOCK NUMBER: 16729-0115-05
| 20.00 |
| EA |
| ______________ |
| ______________ |
Mitoxantrone 25mg
LOCAL STOCK NUMBER: 63323-0132-12
| 18.00 |
| EA |
| ______________ |
| ______________ |
Mycophenolate mofetil 500mg
LOCAL STOCK NUMBER: 60429-0070-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Nivolumab 100mg
LOCAL STOCK NUMBER: 00003-3774-12
| 18.00 |
| EA |
| ______________ |
| ______________ |
Nivolumab 240mg
LOCAL STOCK NUMBER: 00003-3734-13
| 19.00 |
| EA |
| ______________ |
| ______________ |
Nivolumab 40mg
LOCAL STOCK NUMBER: 00003-3772-11
| 12.00 |
| EA |
| ______________ |
| ______________ |
Ocrelizumab 300mg
LOCAL STOCK NUMBER: 50242-0150-01
| 22.00 |
| EA |
| ______________ |
| ______________ |
Ondansetron 40mg
LOCAL STOCK NUMBER: 72266-0124-01
| 22.00 |
| EA |
| ______________ |
| ______________ |
Ondansetron 4mg
LOCAL STOCK NUMBER: 72266-0123-25
| 20.00 |
| EA |
| ______________ |
| ______________ |
Oxaliplatin 100mg
LOCAL STOCK NUMBER: 43066-0018-01
| 19.00 |
| EA |
| ______________ |
| ______________ |
Oxaliplatin 50mg
LOCAL STOCK NUMBER: 00703-3985-01
| 19.00 |
| EA |
| ______________ |
| ______________ |
Paclitaxel 300mg
LOCAL STOCK NUMBER: 61703-0342-50
| 20.00 |
| EA |
| ______________ |
| ______________ |
Paclitaxel 100mg
LOCAL STOCK NUMBER: 61703-0342-22
| 19.00 |
| EA |
| ______________ |
| ______________ |
Paclitaxel 30mg
LOCAL STOCK NUMBER: 61703-0342-09
| 18.00 |
| EA |
| ______________ |
| ______________ |
Paclitaxel Protein-Bound 100mg
LOCAL STOCK NUMBER: 68817-0134-50
| 18.00 |
| EA |
| ______________ |
| ______________ |
Paclitaxel Protein-Bound 200mg
LOCAL STOCK NUMBER: 60505-6230-04
| 21.00 |
| EA |
| ______________ |
| ______________ |
Palonosetron 0.25mg
LOCAL STOCK NUMBER: 63323-0673-05
| 21.00 |
| EA |
| ______________ |
| ______________ |
Pamidronate 30mg
LOCAL STOCK NUMBER: 67457-0430-10
| 21.00 |
| EA |
| ______________ |
| ______________ |
Pamidronate 90mg
LOCAL STOCK NUMBER: 61703-0326-18
| 19.00 |
| EA |
| ______________ |
| ______________ |
Panitumumab 100mg
LOCAL STOCK NUMBER: 55513-0954-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Panitumumab 400mg
LOCAL STOCK NUMBER: 55513-0956-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Pemetrexed 500mg
LOCAL STOCK NUMBER: 00338-0722-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Pertuzumab 420mg
LOCAL STOCK NUMBER: 50242-0145-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Polatuzumab Vedotin-piiq 30mg
LOCAL STOCK NUMBER: 50242-0103-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Ramucirumab 100mg
LOCAL STOCK NUMBER: 00002-7669-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Ramucirumab 500mg
LOCAL STOCK NUMBER: 00002-7678-01
| 12.00 |
| EA |
| ______________ |
| ______________ |
Risankizumab-rzaa 150mg
LOCAL STOCK NUMBER: 00074-2100-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Rituximab-pvvr 500mg
LOCAL STOCK NUMBER: 00069-0249-01
| 20.00 |
| EA |
| ______________ |
| ______________ |
Trastuzumab -dttb 150mg
LOCAL STOCK NUMBER: 78206-0147-01
| 18.00 |
| EA |
| ______________ |
| ______________ |
Vedolizumab 300mg
LOCAL STOCK NUMBER: 64764-0300-20
| 21.00 |
| EA |
| ______________ |
| ______________ |
Vinblastine 10mg
LOCAL STOCK NUMBER: 63323-0278-10
| 21.00 |
| EA |
| ______________ |
| ______________ |
Vincristine 1mg
LOCAL STOCK NUMBER: 00703-4402-11
| 20.00 |
| EA |
| ______________ |
| ______________ |
Vincristine 2mg
LOCAL STOCK NUMBER: 00703-4412-11
| 20.00 |
| EA |
| ______________ |
| ______________ |
Vinorelbine 50mg
LOCAL STOCK NUMBER: 45963-0607-56
| 1,677.00 |
| EA |
| ______________ |
| ______________ |
Facility Patient Fees, USP 797 Fees, USP 800 Fees, Delivery Fees, Chemoembolic Mixing Fees, Exact Volume Requirement Fees, & Intrathecal Mixing Fees
LOCAL STOCK NUMBER: FEES1
| 50.00 |
| EA |
| ______________ |
| ______________ |
STAT Order Fees
LOCAL STOCK NUMBER: FEES2
| GRAND TOTAL |
| ______________ |
B.3 DELIVERY SCHEDULE
| ITEM NUMBER |
| QUANTITY |
| DELIVERY DATE |
| ALL |
| SHIP TO: |
| Department of Veterans Affairs |
Kansas City VA Medical Center 4801 East Linwood Boulevard Kansas City, MO 64128 2226
USA
ALL
B.4 TERMS AND CONDITIONS
The Contractor agrees to the following terms of a Blanket Purchase Agreement (BPA) EXCLUSIVELY WITH the Department of Veterans Affairs:
B.5 ADMINISTRATIVE DATA
A Blanket Purchase Agreement (BPA) is hereby established between and the Department of Veterans Affairs under the following terms and conditions incorporated in this BPA:
Primary Point of Contact:
Alternate Point of Contact:
SAM UEI NUMBER:
Cognizant Office (Include complete address):
Network Contracting Office (NCO) 15 3450 S 4th Street Trafficway Leavenworth KS 66048
B.6 PRICING DATA
1. The prices included on the BPA list (or applicable "discounted" rates submitted in a proposal response to an RFQ resulting in award) that are in effect on the effective date of an order shall govern that order's basic performance period. With regard to any option years, which are later exercised, the proposed option year rates as incorporated into the order award are in effect until such time, if applicable, that the contractor has been authorized a rate increase culminating from a negotiation with the Contracting Officer.
2. The BPA holder can voluntarily reduce offered prices at any time by giving 24-hour advance notice (by facsimile or electronic-mail) to the Department of Veterans Affairs/Contracting Officer. This BPA also allows for additional discounts if a "large order" is placed at one time. An advanced notice is not required for discounts offered for only an individual order. Whether an order is large enough to warrant such a discount is subject to the discretion of the BPA holder.
3. The BPA holder may also increase BPA prices at any time. Any BPA price increase shall not take effect until the Department of Veterans Affairs Contracting Officer receives written notification (U.S. mail, facsimile, or electronic mail). Any order already issued shall not be affected by any change to BPA pricing. The prices offered under this BPA will undergo annual review by the Department of Veterans Affairs Contracting Officer.
B.7 OPTION TO EXTEND THE TERM OF THE BPA
a. The Government may extend the term of this BPA by written notice to the Contractor at any time prior to the expiration of the BPA, provided that the Government shall give the Contractor a preliminary written notice of its intent to extend at least 30 days before the BPA expires. The preliminary notice does not commit the Government to an extension.
b. If the Government exercises this option, the extended BPA shall be considered to include this option provision.
B.8 SEGREGATION OF COSTS
a. The "Payments under Time-and-Materials and Labor-Hour Contracts" clause provides for reimbursement to the contractor of costs incurred for certain items and services purchased directly for the contract, subject to certain limitations set forth in the clause. Such items may include the lease/purchase of equipment, travel expenses for Government- directed travel, consumable materials, tuition and registration fees for specialized training, and other services or items acquired for the Government's account under the Government Property clause. The items and services which the BPA holder is authorized to purchase on a cost- reimbursement basis shall be limited to only those specific items and services described in the order(s) issued to the BPA holder as authorized for purchase.
b. The BPA holder shall segregate costs associated with materials and other items authorized to be purchased on a cost-reimbursement basis (to be specified in each order) from other costs associated with the performance of this contract in such a manner that at any time the costs subject to reimbursement under each order shall be readily ascertainable.
c. The "Ceiling Price" referred to in the "Payments under Time and Materials and Labor-Hour Contracts" clause shall be the ceiling price as stated in each order.
B.9 GENERAL SERVICES ORDERS
a. The BPA holder shall furnish all the necessary qualified personnel, materials, facilities and management resources to furnish the services set forth in the Statement of Objectives (SOO) or the Performance Work Statement (PWS) within the terms specified and at the price(s) stated.
b. It is understood and agreed that the BPA holder shall provide Fixed-Price proposals when requested by the Contracting Officer (CO). The contractor's proposal shall be priced using labor rates and labor categories here in provided. The CO will issue Fixed Priced Orders upon completion of negotiations of contractor proposals.
B.10 AUTHORIZED LIMITS
The Government estimates, but does not guarantee, that individual BPA Orders placed against this Agreement may reach $50,000.00/per Order. This Order Limit may be increased by mutual agreement of the parties as necessary, in whole or part. The authorized Ceiling Limit of the Agreement is set at $4,000,000.00 over the period covered by the Agreement; this ceiling is also not a guarantee. The Ceiling Limit may also be raised in association with Order Limit increases or other conditions which, by mutual agreement of the parties, maybe considered necessary. Authorization for individual orders above the stated order and/or Ceiling Limits must be coordinated through the Contracting Officer before larger valued orders can be issued and prior to commencement of work. All unauthorized work, regardless of amount, will be processed through the ratification process.
B.11 OBLIGATION OF FUNDS
This BPA does not obligate any funds. The Government is obligated only to the extent of authorized orders actually issued under the BPA by the Contracting Officer.
B.12 INVOICES
a. Inspection and acceptance shall be accomplished as follows: The Government, for all services furnished under any resulting order, hereby designates the COR in the program office as the point of final inspection and acceptance. The BPA holder will submit each invoice, including all back-up data, to the Contracting Officer (CO) for review and signature. When the CO receives an accurate and complete invoice, he/she will return a signed copy to the BPA holder within five (5) working days. If the invoice is incomplete or inaccurate, the CO will return the unsigned invoice to the BPA holder for correction. The Contracting Officer will then forward the signed invoice to the Chief Financial Officer (CFO) for payment. Final payment for each order will be accomplished by final invoice accompanied by a receiving report.
b. An itemized invoice shall be submitted to the CO at least monthly or upon expiration of this BPA, whichever occurs first, for all deliveries made during a billing period and for which payment has not been received. Copies of delivery tickets shall support these invoices. "Approved-for-payment" invoices will be submitted to the payment address specified on each individual order issued under this BPA.
B.13 PERIOD OF PERFORMANCE
This BPA expires on 12-31-2023 or such later ending date as determined by the exercise of any option.
B.14 AUTHORIZED INDIVIDUALS
Individuals Authorized to Place Orders:
DVA authorizes the following entities to place orders:
| Kansas City VA Medical Center Pharmacy Services |
| NCO 15 Contracting Office |
B.15 ORDER FORMAT
Orders will be placed against this BPA via e-mail, Electronic Data Interchange (EDI), FAX, or in hardcopy format. Each individual BPA Order will describe the tasks, services and deliverables required.
B.16 AUTHORIZED REPRESENTATIVES
The primary Contracting Officer (CO) for this Agreement is:
| Courtney Chattman |
| Contracting Officer |
| Department of Veterans Affairs |
| Network Contracting Office (NCO) 15 |
| 3450 S 4th Street Trafficway |
| Leavenworth, KS 66048 |
| Courtney.Chattman@va.gov |
The Primary Contracting Officer's Representative (COR) for projects under this Agreement is:
TBD
The Secondary Contracting Officer's Representative (COR) for projects under this Agreement is:
TBD
The Primary and/or Secondary COR will be responsible for technical monitoring of the contractor's performance and deliveries. The COR and the Contractor's Representative shall work together to ensure that all contractual requirements are being met. The COR will interpret specifications or technical portions of the work. The COR is not authorized to perform, formally or informally, any of the following actions:
(1) Promise, award, agree to award, or execute any contract, contract modification, or notice of intent that changes or may change this contract;
(2) Waive or agree to modification of the delivery schedule;
(3) Make any final decision on any contract matter subject to the Disputes Clause;
(4) Terminate, for any reason, the contractor's right to proceed;
(5) Obligate in any way, the payment of money by the Government. Only a warranted Contracting Officer is authorized to obligate funds on this or any other contract action.
The contractor shall immediately notify the Contracting Officer in writing if the COR has taken an action (or fails to take action) or issues directions (written or oral) that the contractor considers to exceed the above limitations.
The contractor shall provide the Contracting Officer information copies of all correspondence to the COR.
B.17 FEDERAL HOLIDAYS
Unless specifically authorized in writing by the Contracting Officer, no services will be provided, and no charges will be incurred and/or billed to any order on this contract on any of the Federal Holidays listed below.
| New Year’s Day |
| Labor Day |
| Birthday of Martin Luther King, Jr. |
| Columbus Day |
| Washington’s Birthday |
| Veterans' Day |
| Memorial Day |
| Thanksgiving Day |
| Juneteenth |
| Christmas Day |
Independence Day
B.18 ORDERING MANAGEMENT
a. Order Management Requirements: Delivery of services shall be implemented only if directed by an order. The BPA holder shall respond in no more than 1 working days from the issuance of the order to identify the Contractor's Task Leader. The Contractor's Task Leader shall arrange for a meeting between the BPA holder Task Leader and the COR to obtain the necessary detailed information to proceed with the task.
b. Order Procedures: Each Request for Proposal for an order will contain a Statement of Objectives (SOO), or other performance-based work statement, describing the program to be supported, a description of the task, evaluation criteria, the deliverables, an order start and completion date, and the COR. The BPA holder(s) solicited will respond to the SOO with a Performance Work Statement (PWS), a proposed technical solution including labor mix and hours, and a proposed ceiling or fixed price for the order. Note: The Government will accept order proposals only from BPA holders that it has solicited. The PWS and labor mix will be incorporated into any resulting order. The proposed technical solution may also be incorporated in the order. The BPA holder on a per site basis will assign the Task Leader.
c. Order Accounting: The BPA holder's order accounting system shall provide traceability of all labor hour and cost reimbursable elements (e.g., travel, material, other authorized direct costs) ordered by each program's funding citation's Accounting Classification Reference Number (i.e., "acrn" assigned at the "SubCLIN" level in Section B), if required by the program office. Otherwise, traceability shall be at the CLIN level, to include segregation by Government appropriation (i.e., "color of money"), set forth in the order. Under no circumstances will any invoice exceed the period of performance, hours or dollar amount (ceiling price) for any funded order. The BPA holder will separately track and invoice US Government and FMS charges. All invoices submitted for payment shall clearly identify:
1. Government order number.
2. Period of performance
3. Amount due by CLIN
4. Labor hours provided per labor category
d. The BPA holder shall prepare and maintain a Funds and Man-hour Expenditure Report for each order. The BPA holder will submit reports, in contractor format, to the COR and Contracting Officer on a regular basis as defined by each order. Reporting shall include schedule by task, labor hour expenditures by labor category by task, cost reimbursable elements, calendar of supported travel, reviews, meetings and briefings, deliverables status and an estimated completion date. The report shall also identify the most significant cost driver(s) for each task (i.e., Schedule, Type of Program, and Complexity), the value of the driver, and a brief explanation. The Government shall identify a standard set of activities and definitions. For each task, the BPA holder shall identify the approximate percentage of hours allocated to those activities. Until such a time as the Government provides this standard set of activities, the BPA holder will not be required to provide this information. The Funds and Man-hour Expenditure Report will be prepared and submitted by those individuals covered by company overhead and will not be directly charged to any specific labor category on a specific order. These reports will be submitted electronically.
e. Closeout Procedures: To facilitate closeout of individual orders placed under this BPA, within thirty (30) days of completion of any individual order, the BPA holder shall present a final invoice to the Contracting Officer that contains a complete accounting of hours expended by category, the prices associated with those hours, any cost reimbursable expenses, and a proposed final price. If the Government concurs with the invoice and the proposed final price is within the ceiling price of the order, the Government will issue an order modification converting the order to a firm fixed price order at the proposed final price.
B.19 PERFORMANCE
The following terms and conditions are applicable:
a. All services will be initiated within 5 calendar days following receipt of a valid order, unless otherwise specified in the order.
b. The BPA holder shall be familiar with Federal Government and Department of Veterans Affairs acquisition regulations, directives and instructions. If a particular document is required in a specific order, it will be cited within the order's PWS.
c. The BPA holder shall not provide technical direction to any other acquisition BPA holder(s) or government personnel at any time. Neither shall the Government directly supervise BPA holder employees. The BPA holder Task Leader should conduct day to day supervision of BPA holder personnel wherever the BPA holder personnel are located. All direction of the BPA holder shall be through the Contracting Officer (CO) of the ordering organization specified in each individual order. Technical "tasking" assignments for the BPA holder will be transmitted by the program office's COR (or program manager) to the BPA holder's Task Leader.
d. The "ordering period" will run from BPA award to 12-31-2023, or until such ending date of any option year, which may be exercised under the Agreement. The "performance period" will terminate with the end of the BPA, unless the ordering CO elects to extend performance as provided under the BPA. If the ordering CO elects to extend performance beyond the end of the BPA, he/she may extend performance up to six (6) months beyond the end of the order period.
e. Capitalization Requirements: The BPA holder shall provide their employees sufficient computer equipment to support orders. The BPA holder shall be able to support the automatic transmission of unclassified data only to the requiring Program Office by modem if so requested. Any computers connected to or transmits to (connected or via magnetic media) the government shall be properly protected from computer viruses. The BPA holder shall be capable of supporting the software packages utilized by Department of Veterans Affairs for the indicated processors. Specific software packages utilized within a program office shall be stated in the order PWS if it is other than Microsoft Office Professional or Microsoft Project.
f. Cancellation: This BPA may be canceled if the BPA holder fails to perform in accordance with the terms and conditions of this BPA, any order established under this BPA, or if deemed as in the best interests of the Government. The BPA holder must strictly comply with all terms and conditions, or the Department of Veterans Affairs/ Contracting Officer may determine that performance by the BPA holder has been unsatisfactory and cancel this BPA.
B.20 MANAGEMENT CONTROL
The BPA holder shall provide to the Contracting Officer (CO) a list of all teaming partners or subcontractors within 15 calendar days after order award. As subcontractors and/or teaming partners are added, and/or deleted, an updated listing will be provided to the CO within 15 calendar days of such change. All BPA holder personnel shall display identification badges at all times while charging hours to the order or at a government or government contractor location. Authorized Government personnel shall accompany all visits to Department of Veterans Affairs Program Offices unless other specific arrangements have been made.
B.21 PRECEDENCE
36C25523Q0553 The Terms and conditions included in this BPA apply to all purchases made pursuant to it. In the event of an inconsistency between the provisions of this BPA and the Contractor's invoice, the provisions of this BPA will take precedence.
Page 1 of Page 1 of
SECTION C - CONTRACT CLAUSES
ADDENDUM to FAR 52.212-4 CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES Clauses that are incorporated by reference (by Citation Number, Title, and Date), have the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available.
The following clauses are incorporated into 52.212-4 as an addendum to this contract:
C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)
This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):
(End of Clause)
| FAR Number |
| Title |
| Date |
| 52.203-16 |
| PREVENTING PERSONAL CONFLICTS OF INTEREST |
| JUN 2020 |
| 52.203-17 |
| CONTRACTOR EMPLOYEE WHISTLEBLOWER RIGHTS AND REQUIREMENT TO INFORM EMPLOYEES OF WHISTLEBLOWER RIGHTS |
| JUN 2020 |
| 52.204-4 |
| PRINTED OR COPIED DOUBLE-SIDED ON POSTCONSUMER FIBER CONTENT PAPER |
| MAY 2011 |
| 52.204-13 |
| SYSTEM FOR AWARD MANAGEMENT MAINTENANCE |
| OCT 2018 |
| 52.204-18 |
| COMMERCIAL AND GOVERNMENT ENTITY CODE MAINTENANCE |
| AUG 2020 |
| 52.204-21 |
| BASIC SAFEGUARDING OF COVERED CONTRACTOR INFORMATION SYSTEMS |
| NOV 2021 |
| 52.224-1 |
| PRIVACY ACT NOTIFICATION |
| APR 1984 |
| 52.224-2 |
| PRIVACY ACT |
| APR 1984 |
| 52.227-17 |
| RIGHTS IN DATA—SPECIAL WORKS |
| DEC 2007 |
| 52.212-4 |
| CONTRACT TERMS AND CONDITIONS—COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES |
| DEC 2022 |
| 52.232-40 |
| PROVIDING ACCELERATED PAYMENTS TO SMALL BUSINESS SUBCONTRACTORS |
| MAR 2023 |
C.2 VAAR 852.201-70 CONTRACTING OFFICER'S REPRESENTATIVE (DEC 2022)
The Contracting Officer reserves the right to designate representatives to act for him/her in furnishing technical guidance and advice or generally monitor the work to be performed under this contract. Such designation will be in writing and will define the scope and limitation of the designee’s authority. A copy of the designation letter shall be furnished to the Contractor.
(End of Clause)
C.3 VAAR 852.203-70 COMMERCIAL ADVERTISING (MAY 2018)
The Contractor shall not make reference in its commercial advertising to Department of Veterans Affairs contracts in a manner that states or implies the Department of Veterans Affairs approves or endorses the Contractor’s products or services or considers the Contractor’s products or services superior to other products or services.
(End of Clause)
C.4 VAAR 852.204-71 INFORMATION AND INFORMATION SYSTEMS SECURITY (FEB 2023)
(a) Definitions. As used in this clause—Business Associate means an entity, including an individual (other than a member of the workforce of a covered entity), company, organization or another covered entity, as defined by the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule, that performs or assists in the performance of a function or activity on behalf of the Veterans Health Administration (VHA) that involves the creating, receiving, maintaining, transmitting of, or having access to, protected health information (PHI). The term also includes a subcontractor of a business associate that creates, receives, maintains, or transmits PHI on behalf of the business associate.
Business Associate Agreement (BAA) means the agreement, as dictated by the Privacy Rule, between VHA and a business associate, which must be entered into in addition to the underlying contract for services and before any release of PHI can be made to the business associate, in order for the business associate to perform certain functions or activities on behalf of VHA.
Information system means a discrete set of information resources organized for the collection, processing, maintenance, use, sharing, dissemination, or disposition of information whether automated or manual.
Information technology (see FAR 2.101) also means Information and Communication Technology (ICT).
Information technology-related contracts means those contracts which include services (including support services), and related resources for information technology as defined in 802.101.
Privacy officer means the VA official with responsibility for implementing and oversight of privacy related policies and practices that impact a given VA acquisition.
Sensitive personal information means, with respect to an individual, any information about the individual maintained by VA, including but not limited to the following:
(1) Education, financial transactions, medical history, and criminal or employment history.
(2) Information that can be used to distinguish or trace the individual’s identity, including but not limited to name, social security number, date and place of birth, mother’s maiden name, or biometric records.
Security plan means a formal document that provides an overview of the security requirements for an information system or an information security program and describes the security controls in place or planned for meeting those requirements.
VA Information Security Rules of Behavior for Organizational Users (VA National Rules of Behavior) means a set of VA rules that describes the responsibilities and expected behavior of users of VA information or information systems.
VA sensitive information means all VA data, on any storage media or in any form or format, which requires protection due to the risk of harm that could result from inadvertent or deliberate disclosure, alteration, or destruction of the information and includes sensitive personal information. The term includes information where improper use or disclosure could adversely affect the ability of VA to accomplish its mission, proprietary information, records about individuals requiring protection under various confidentiality provisions such as the Privacy Act and the HIPAA Privacy Rule, and information that can be withheld under the Freedom of Information Act. Examples of VA sensitive information include the following:
individually-identifiable medical, benefits, and personnel information; financial, budgetary, research, quality assurance, confidential commercial, critical infrastructure, investigatory, and law enforcement information; information that is confidential and privileged in litigation such as information protected by the deliberative process privilege, attorney work-product privilege, and the attorney-client privilege; and other information which, if released, could result in violation of law or harm or unfairness to any individual or group, or could adversely affect the national interest or the conduct of Federal programs.
(b) General. Contractors, subcontractors, their employees, third-parties, and business associates with access to VA information, information systems, or information technology (IT) or providing and accessing IT-related goods and services, shall adhere to VA Directive 6500, VA Cybersecurity Program, and the directives and handbooks in the VA 6500 series related to VA information (including VA sensitive information and sensitive personal information and information systems security and privacy), as well as those set forth in the contract specifications, statement of work, or performance work statement. These include, but are not limited to, VA Handbook 6500.6, Contract Security; and VA Directive and Handbook 0710, Personnel Security and Suitability Program, which establishes VA’s procedures, responsibilities, and processes for complying with current Federal law, Executive Orders, policies, regulations, standards and guidance for protecting VA information, information systems (see 802.101, Definitions) security and privacy, and adhering to personnel security requirements when accessing VA information or information systems.
(c) Access to VA information and VA information systems.
(1) Contractors are limited in their request for logical or physical access to VA information or VA information systems for their employees, subcontractors, third parties and business associates to the extent necessary to perform the services or provide the goods as specified in the contracts, agreements, task, delivery or purchase orders.
(2) All Contractors, subcontractors, third parties, and business associates working with VA information are subject to the same investigative requirements as those of VA appointees or employees who have access to the same types of information. The level and process of background security investigations for contractors to access VA information and VA information systems shall be in accordance with VA Directive and Handbook 0710, Personnel Security and Suitability Program.
(3) Contractors, subcontractors, third parties, and business associates who require access to national security programs must have a valid security clearance.
(4) HIPAA Business Associate Agreement requirement. Contractors shall enter into a Business Associate Agreement (BAA) with VHA, VA’s Covered Entity, when contract requirements and access to protected health information is required and when requested by the Contracting Officer, or the Contracting Officer’s Representative (COR) (see VAAR 824.103–70).
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .